AU615553B2 - Aqueous dialysis and rinsing solution for intraperitoneal administration - Google Patents

Aqueous dialysis and rinsing solution for intraperitoneal administration Download PDF

Info

Publication number
AU615553B2
AU615553B2 AU36636/89A AU3663689A AU615553B2 AU 615553 B2 AU615553 B2 AU 615553B2 AU 36636/89 A AU36636/89 A AU 36636/89A AU 3663689 A AU3663689 A AU 3663689A AU 615553 B2 AU615553 B2 AU 615553B2
Authority
AU
Australia
Prior art keywords
parts
amino acids
solution according
amino acid
dialysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU36636/89A
Other languages
English (en)
Other versions
AU3663689A (en
Inventor
Volker Bartz
Volker Steudle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius SE and Co KGaA
Original Assignee
Fresenius SE and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius SE and Co KGaA filed Critical Fresenius SE and Co KGaA
Publication of AU3663689A publication Critical patent/AU3663689A/en
Application granted granted Critical
Publication of AU615553B2 publication Critical patent/AU615553B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU36636/89A 1988-06-22 1989-06-20 Aqueous dialysis and rinsing solution for intraperitoneal administration Ceased AU615553B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3821043A DE3821043A1 (de) 1988-06-22 1988-06-22 Dialysier- und spuel-loesung zur intraperitonealen verabreichung
DE3821043 1988-06-22

Publications (2)

Publication Number Publication Date
AU3663689A AU3663689A (en) 1990-01-04
AU615553B2 true AU615553B2 (en) 1991-10-03

Family

ID=6356999

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36636/89A Ceased AU615553B2 (en) 1988-06-22 1989-06-20 Aqueous dialysis and rinsing solution for intraperitoneal administration

Country Status (4)

Country Link
EP (1) EP0347714A3 (enExample)
JP (1) JPH0253723A (enExample)
AU (1) AU615553B2 (enExample)
DE (1) DE3821043A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940052A1 (de) * 1989-12-04 1991-06-06 Nephro Medica Pharma Dialysier- und spuelloesung zur intraperitonealen verabreichung
DE59101623D1 (de) * 1990-01-12 1994-06-23 Nephro Medica Pharma Bicarbonat und Calcium enthaltende Infusions- und Dialysierlösung.
US5827820A (en) * 1992-04-06 1998-10-27 Baxter International Inc. Aqueous peritoneal dialysis solution
EP0626845B1 (en) * 1992-12-22 2002-10-23 Baxter International Inc. Improved amino acid solutions for treatment of peritoneal dialysis patients
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
US6537976B1 (en) * 1997-08-07 2003-03-25 Ajay Gupta Dialysis solutions containing water soluble vitamins and nutrients
US6770148B1 (en) 1998-12-04 2004-08-03 Baxter International Inc. Peritoneal dialysis solution containing modified icodextrins
CN1688300A (zh) * 2002-07-01 2005-10-26 株式会社Jms 含有牛磺酸的腹膜透析液
US7053059B2 (en) 2003-07-25 2006-05-30 Baxter International Inc. Dialysis solutions with reduced levels of glucose degradation products
US20100187476A1 (en) * 2007-08-15 2010-07-29 Yasumi Yugari Peritoneal dialysate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218900A2 (en) * 1985-09-10 1987-04-22 Research Corporation Technologies, Inc. Osmotic agents for peritoneal dialysis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2531201C2 (de) * 1975-07-12 1986-05-28 Fresenius AG, 6380 Bad Homburg Aminosäure-Infusionslösungen für die Verwendung bei Frühgeburten bis Kleinkindern
DE2531204C2 (de) * 1975-07-12 1987-01-22 Fresenius AG, 6380 Bad Homburg L-Aminosäuregemische für die parenterale oder orale Ernährung
GB1496254A (en) * 1975-07-28 1977-12-30 Ajinomoto Kk Nutritive infusion solution and its production
DE2636828A1 (de) * 1976-08-16 1978-02-23 Fresenius Chem Pharm Ind L-amonosaeurengemische fuer die behandlung von leberinsuffizienz sowie die herstellung derartiger gemische
DE2642768A1 (de) * 1976-09-23 1978-03-30 Fresenius Chem Pharm Ind Essentielle und nicht essentielle l-aminosaeuren enthaltendes gemisch zur behandlung von leberinsuffizienz
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
JPS5536457A (en) * 1978-09-08 1980-03-14 Ajinomoto Co Inc Amino acid infusion
DE2946563C2 (de) * 1979-11-17 1987-04-30 B. Braun Melsungen Ag, 3508 Melsungen Aminosäurelösung zur parenteralen Infusion
JPS58500563A (ja) * 1981-04-27 1983-04-14 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド グルコ−ス、アミノ酸およびインシユリンを含む透析液
US4357343A (en) * 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure
JPS60123413A (ja) * 1983-12-05 1985-07-02 Ajinomoto Co Inc 新アミノ酸輸液
DE3414491A1 (de) * 1984-04-17 1985-10-24 Hans Dr. 8202 Bad Aibling Dietl L-aminosaeurengemische fuer die parenterale und orale anwendung bei nierenerkrankungen
DE3428201A1 (de) * 1984-07-31 1986-02-06 Laevosan-Gesellschaft mbH & Co. KG, Linz Loesungen fuer die peritonealdialyse
CA1239586A (en) * 1984-10-02 1988-07-26 Dimitrios G. Oreopoulos Dialysis solution containing amino acids
DE3620845A1 (de) * 1986-06-21 1987-12-23 Dieter Von Dr Horsten Infusionsloesung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218900A2 (en) * 1985-09-10 1987-04-22 Research Corporation Technologies, Inc. Osmotic agents for peritoneal dialysis

Also Published As

Publication number Publication date
EP0347714A2 (de) 1989-12-27
EP0347714A3 (de) 1990-12-27
DE3821043C2 (enExample) 1991-12-12
JPH0253723A (ja) 1990-02-22
DE3821043A1 (de) 1989-12-28
AU3663689A (en) 1990-01-04

Similar Documents

Publication Publication Date Title
US3950529A (en) Amino acid formulations for patients with liver disease and method of using same
US4434160A (en) Nutrient solution for complete parenteral feeding and for increased energy production
US4357343A (en) Nutritional composition for management of renal failure
KR100309972B1 (ko) 복막투석환자치료용의개량아미노산용액
Heidland et al. Expert working group report on nutrition in adult patients with renal insufficiency (Part 2 of 2)
US4920098A (en) Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
EP0716607B1 (en) Biochemically balanced peritoneal dialysis solutions
US4962121A (en) Method and composition for treating neurological diseases such as migraine
US5719119A (en) Parenteral nutrition therapy with amino acids
AU615553B2 (en) Aqueous dialysis and rinsing solution for intraperitoneal administration
AU609596B2 (en) Aqueous dialysis and rinsing solution for intraperitoneal administration
JPH031287B2 (enExample)
AU8152087A (en) Liquid nutritional compositions
US7932291B2 (en) Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
WO1987003806A1 (en) Parenteral nutrition therapy with amino acids
JP3182564B2 (ja) 栄養組成物
JPH0116809B2 (enExample)
KR100907938B1 (ko) 발기 기능장애의 치료를 위한 알카노일 ｌ-카르니틴의 용도
EP0146474A2 (fr) Composition nutritive contenant de l'acide alpha-cétoisocaproique ou un de ses sels
EP0355453A2 (en) Use of 3-hydroxybutyric acid as an energy source
JPH0328403B2 (enExample)
MX2007010814A (es) Solucion para dialisis peritoneal que contiene carnitina, que tiene biocompatibilidad mejorada.
JP2003128534A (ja) コリン配合輸液剤
CM THE importance of dietary management